Research Article Volume 7 Issue 1
1Centro de Medicina de Reabilitação da Região Centro – Rovisco Pais, Portugal
2Centro Hospitalar do Médio Tejo, Serviço de Pneumologia, Portugal
3Centro Hospitalar do Baixo Vouga, Serviço de Medicina Física e de Reabilitação, Portugal
4Universidade de Coimbra, CIEPQPF, Departamento de Engenharia Química, Portuga
5Faculdade de Medicina, Universidade de Coimbra, Portugal
Correspondence: Pedro Carvalho Sá, Centro de Medicina de Reabilitação da Região Centro , Rovisco Pais, Quinta da Fonte Quente, Tocha, Cantanhede, Portugal, 3064-908, Tel 00351912378922
Received: December 28, 2021 | Published: January 6, 2022
Citation: Carvalho SP, Ferro I, Pires C, et al. Stroke - shoulder pain and upper limb function. Int Phys Med Rehab J. 2022;7(1):1-4. DOI: 10.15406/ipmrj.2022.07.00293
Introduction: Stroke causes disability and pain, especially shoulder pain. Often, shoulder pain, has a not completely known mechanism and evolution.1,2
Objectives: Assess shoulder pain and its impact in upper limb function, in patients who had suffered a stroke within 6 months.
Methods: Observational study. Included patients at discharge from an inpatient rehabilitation centre, from November 2019 until February 2020. Assessment was done using validated Portuguese versions of the Brief Pain Inventory (BPI) and Fugl Meyer Assessment Scale (FMAS).
Results: Of 32 patients screened, 26 fulfilled the inclusion criteria, 7 were females (26 ,9 %), with mean age of 60,7±10 years. Mean values of BPI Severity and Interference were 3,2±1,6 and 2,4±1,8, respectively. The mean values of the FMAS Motor Function and Passive Articular Movement were 38,8±23,2 and 20,3±2,3, respectively. Analysing the association between both subscales of BPI and both Subscales of FMAS negative correlations were found to be statistically significant with a confidence interval of 95% but no statistically significant correlation was found between BPI Severity and FMAS motor function. Six patients (23%) received a local injection for shoulder pain. Analysing both groups, BPI Severity and both subscales of FMAS showed a statistically significant difference (p-values of 0,0083, 0,0031 and 0,0056, respectively) for a Wilcoxon/Kruskal-Wallis test with a confidence interval of 95%.
Discussion/Conclusions: Patients with voluntary upper limb movements after a stroke tend to have less shoulder pain. Local injection was an effective intervention for shoulder pain. The major limitation of this study is the small sample size.
BPI, Brief Pain Inventory; FMAS, Fugl Meyer Assessment Scale; INE, National Institute of Statistics; SD, standard deviation
Cerebrovascular disease is a major cause of death and it is the leading cause of disability in adults - in 2013, there were globally 6.5 million deaths from stroke and 113 million DALYs due to stroke.1 In Portugal, data from the National Institute of Statistics (INE) revealed that cardiovascular diseases were the major cause of death (29.8%) in 2015 with stroke being the most frequent cause of death within this group of diseases.
Stroke can also be a cause of pain that can occur through a variety of mechanisms - central post-stroke pain, complex regional pain syndrome, and pain associated with spasticity, among other shoulder pathologies and dysfunctions.2 Shoulder pain is one of the common symptoms related to stroke and it can be associated with various mechanisms and have different clinical courses from one patient to another.2–4
Pain is a limiting aspect of functionality and has a major negative impact on the quality of life and in multiple areas of functioning such as cognition, emotion, and behavior.5,6
The Brief Pain Inventory (BPI) is a self-administered questionnaire for chronic pain conditions. It is available in a short (nine items) and long (17 items) form. The BPI short form is more frequently used. The questionnaire is composed of pain drawing diagrams about pain severity, pain relief treatment or medication, and pain interference with multiple aspects of the patient’s life.7
One of the most widely recognized and clinically relevant measures of body function impairment after stroke is the Fugl-Meyer Assessment Scale (FMAS). Of its 5 domains (motor, sensory, balance, range of motion, joint pain), the motor domain has well-established reliability and validity as an indicator of motor impairment severity across different stroke recovery time points.8
This study focuses on shoulder pain and its impact in the upper limb function, in patients who recently suffered a stroke (within 6 months of the event).
Study design and data collection
This cross-sectional observational study was performed at an inpatient rehabilitation center from November 2019 till February of 2020. This study was conducted according to STROBE guidelines.
The inclusion criteria of the study were as follows:
The following exclusion criteria were applied:
This protocol was approved by the competent human research ethics committee, from our Rehabilitation Center, and every patient provided informed consent before being enrolled in the study.
For each patient demographic data was collected as well as treatment strategies that were performed in each case. The validated Portuguese versions of the Brief Pain Inventory and of the Fugl Meyer Assessment Scale (upper limb) were used to access both pain and sensorimotor impairment.
Statistical analysis
We summarized the characteristics of study populations using descriptive statistical methods with frequencies and percentage, mean, and standard deviation (SD).
The correlation between the two questionnaires was determined with Spearman correlation with 95% confidence interval. To evaluate the effectiveness of a specific treatment approach the Wilcoxon/Kruskal-Wallis test was used with a confidence interval of 95%.
All calculations were performed using JMP PRO® version 15, SAS Institute Inc.
Outcome measures
The primary goal was to determine whether treatment strategies for hemiplegic shoulder pain were effective. For that we ascertained if there was a statistically significant difference on the grading of the scales used in this study between both groups (the one taking and the other not taking pain medication). Another goal was to establish whether shoulder pain and upper limb function were correlated. This was done by correlating both scales used and see if there was statistical significance between them.
From a total of 32 patients discharged from our Rehabilitation Center in the referred period, 26 fulfilled the inclusion criteria, being that 19 patients were males (73.1%), with a mean age of 60.7±10 years. Thirteen (50%) patients presented with a left hemispheric stroke and 13 (50%) with a right hemispheric stroke. An ischemic stroke was observed in 16 patients (61.5%) and 10 patients (38.5%) had a hemorrhagic stroke. The average time until the onset of shoulder pain was 6±2.5 weeks (min=2; max=12); the average time from the beginning of pain complaints till the study was conducted was 10±4.2 weeks (min=4; max=22). Demographic and disease related data are presented in (Table 1).
Characteristics |
n |
% |
Mean (±SD) |
Age (years) |
60.7±10 |
||
Sex (male) |
19 |
73.1 |
|
Left hemispheric stroke |
13 |
50 |
|
Right hemispheric stroke |
13 |
50 |
|
Ischemic stroke |
16 |
61.5 |
|
- Lacunar anterior circulation infarct (LACI) |
3 |
11.5 |
|
- Parcial anterior circulation infarct (PACI) |
8 |
30.8 |
|
- Total anterior circulation infarct (TACI) |
2 |
7.7 |
|
- Posterior circulation infarct (POCI) |
2 |
7.7 |
|
1 |
3.8 |
||
Hemorrhagic stroke |
10 |
38.5 |
|
Onset of pain after stroke (weeks) |
6±2.5 |
||
Onset of paint until evaluation in the study (weeks) |
|
|
10±4.2 |
Table 1 Demographic and disease related data
The therapeutic strategies performed are displayed in. (Table 2) Twenty-two patients (84.6%) were submitted to physical modalities during physical therapy and 18 patients (69.2%) were included in hydrokinesitherapy during treatment. Eleven patients (42.3%) were given pain medication whereas only 6 patients (23%) received a local injection of an anesthetic or a corticosteroid to ameliorate the pain. Due to a reduced number of patients in each group, both intra-articular and soft tissue injections were grouped.
Therapy |
n |
% |
Physical modalities |
22 |
84.6 |
Hydrokinesiotherapy |
18 |
69.2 |
Pain medication |
11 |
42.3 |
Local injection |
6 |
23.1 |
Assistive devices |
6 |
23.1 |
Botulinum toxin |
4 |
15.4 |
Oral antispasticity medication |
3 |
11.5 |
Supraescapular nerve block |
3 |
11.5 |
Table 2 Therapeutic interventions
The mean value of the BPI domains was 3.2±1.6 for BPI Severity and 2.4±1.8 for BPI Interference. Also, for the FMAS domains, mean FMAS Motor Function was 38.8±23.3 and mean FMAS Passive Articular Movement was 20.3±2.3.
Analyzing the association between both subscales of BPI (subscales Severity and Interference) and both Motor Function and Passive Articular Movement (subscales of FMAS) negative correlations were found to be statistically significant at all correlations tested with a confidence interval of 95%. The exception was the BPI Severity and FMAS passive articular movement, where no statistically significant correlation was found (Table 3).
Scale domain |
Spearman ρ |
p-value |
BPI Severity and FMAS Motor Function |
-0.3273 |
0.1025 |
BPI Severity and FMAS Passive Articular Movement |
-0.4481 |
0.0217 |
BPI Interference and FMAS Motor Function |
-0.408 |
0.0386 |
BPI Interference and FMAS Passive Articular Movement |
-0.4495 |
0.0212 |
Table 3 Spearman correlation between domains of the BPI and FMAS
Treatment approaches and its effects on the domains of the scales used are represented in Table 4 and Table 5. BPI Interference, FMAS Motor Function and Passive Articular Movement differ in a statistical significant way upon the utilization of an injection (p values of 0,0083, 0,0031 and 0,0056) for a Wilcoxon/Kruskal-Wallis test with a confidence interval of 95%. The other interventions did not show statistically significant differences in the domains of the scales used.
BPI domains and therapeutic interventions |
p-value |
BPI Severity with physical modalities |
0.163 |
BPI Severity with hydrokinesiotherapy |
0.7522 |
BPI Severity with pain medication |
0.0912 |
BPI Severity with local injection |
0.0083 |
BPI Interference with physical modalities |
0.2635 |
BPI Interference with hydrokinesiotherapy |
0.2148 |
BPI Interference with pain medication |
0.1792 |
BPI Interference with local injection |
0.1152 |
Table 4 Therapeutic interventions and Brief Pain Inventory
FMAS domains and therapeutic interventions |
p-value |
FMAS Motor Function with physical modalities |
0.1884 |
FMAS Motor Function with hydrokinesiotherapy |
0.3738 |
FMAS Motor Function with pain medication |
0.9586 |
FMAS Motor Function with local injection |
0.0031 |
FMAS Passive Articular Movement with physical modalities |
0.0167 |
FMAS Passive Articular Movement with hydrokinesiotherapy |
0.822 |
FMAS Passive Articular Movement with pain medication |
0.189 |
FMAS Passive Articular Movement with local injection |
0.0056 |
Table 5 Therapeutic interventions and Fugl Meyer Assessment Scale
After a stroke, both active and passive upper limb movement (evaluated through both subscales of FMAS, respectively) were associated with less pain (subscales of BPI); no evaluated pain intervention was in fact effective, except for a local therapeutic injection.
The use of pain medication showed a positive tendency (p=0,0912) – possibly, with a larger sample of patients a statistically significant difference could be shown. It is important to highlight, that only 11 (out of the 26) patients were actually taking pain medication. The others stated that the pain was only present during physiotherapy sessions, and that they did not want to take any medication, even when it was offered.
As ascertained previously, both subscales of the BPI were negatively associated with Motor Function and Passive Articular Movement (subscales of FMAS). So, shoulder pain after stroke is, as showed in this study, of relevance to upper limb movement.Interventions used for its treatment are largely lacking solid evidence. The precise reasons for these results are still unknown. Regardless, some speculation can be made. As previously stated, mechanisms of pain after a stroke seem to be multiple in different patients and maybe more than one present in each patient.2 Understanding the most likely cause of shoulder pain in each patient might enlighten clinicians as to which specific treatment can be more effective.
A recent systematic review for interventions in post-stroke shoulder pain showed positive results for acupuncture, orthoses, botulinum toxin injection, electrical stimulation and aromatherapy.9 However, findings were often inconsistent across outcome measures or follow-up times, reinforcing the lack of evidence and need for individualization and standardization of approaches.
Shoulder pain is relevant as a symptom, but also in a functional level. In a previous study, post-stroke patients with shoulder pain had reduced upper limb function and lower daily functional independence (evaluated with the Functional Independence Measure) when compared to patients without shoulder pain.10 In addition, post-stroke patients with impaired quality of life are likely to be functionally dependent.11 Therefore, managing pain is important, not only for its relief, but also to improve upper limb function, functional independence, and ultimately, for their quality of life.
The most relevant limitations of this study are its cross-sectional design (only one evaluation was conducted) and the small sample of patients included. Also, some interventions were grouped and these groups may be heterogenous. Evaluating specific approaches within each group - for instance, certain types of pain medication or physical modalities - could lead to different results. In spite of this, relevant data was obtained.
Prospective longitudinal studies, beginning in the acute phase after stroke, and maintaining the assessment of patients in the sub-acute period, are necessary for a better knowledge both of the evolution and possible early interventions in shoulder pain after a stroke.
After a stroke both active and passive upcper limb range of movement was associated with less pain. Nevertheless, none of the evaluated pain intervention evaluated was effective except for a local injection. Prospective studies are necessary for a better knowledge both of the evolution and possible interventions in shoulder pain after stroke.
This study was conducted according the World Medical Association Declaration of Helsinki.
The study protocol was approved by our Rehabilitation ethics committee (CMRRC – Rovisco Pais).
Written informed consent was obtained from participants (legal guardian/next of kin) to participate in the study.
None.
The authors have no conflicts of interest to declare.
No sponsor or funding was required to develop this study.
All authors contributed to the development of this article according to the ICMJE Criteria for Authorship.
All data generated or analyzed during this study are included in this article and its supplementary material files. Further enquiries can be directed to the corresponding author.
©2022 Carvalho, et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.